Nexgel End Period Cash Flow from 2010 to 2024

NXGL Stock  USD 3.52  0.09  2.49%   
Nexgel End Period Cash Flow yearly trend continues to be quite stable with very little volatility. End Period Cash Flow may rise above about 3.2 M this year. From the period between 2010 and 2024, Nexgel, End Period Cash Flow regression line of its data series had standard deviation of  3,425,223 and standard deviation of  3,425,223. View All Fundamentals
 
End Period Cash Flow  
First Reported
2019-06-30
Previous Quarter
1.1 M
Current Value
1.1 M
Quarterly Volatility
3.4 M
 
Covid
Check Nexgel financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nexgel's main balance sheet or income statement drivers, such as Depreciation And Amortization of 266.2 K, Total Revenue of 2.1 M or Gross Profit of 650 K, as well as many indicators such as Price To Sales Ratio of 2.81, Dividend Yield of 0.0 or PTB Ratio of 2.44. Nexgel financial statements analysis is a perfect complement when working with Nexgel Valuation or Volatility modules.
  
Check out the analysis of Nexgel Correlation against competitors.

Latest Nexgel's End Period Cash Flow Growth Pattern

Below is the plot of the End Period Cash Flow of Nexgel Inc over the last few years. It is Nexgel's End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nexgel's overall financial position and show how it may be relating to other accounts over time.
End Period Cash Flow10 Years Trend
Slightly volatile
   End Period Cash Flow   
       Timeline  

Nexgel End Period Cash Flow Regression Statistics

Arithmetic Mean1,490,011
Geometric Mean366,186
Coefficient Of Variation229.88
Mean Deviation1,974,951
Median186,000
Standard Deviation3,425,223
Sample Variance11.7T
Range13.3M
R-Value0.44
Mean Square Error10.2T
R-Squared0.19
Significance0.10
Slope333,308
Total Sum of Squares164.3T

Nexgel End Period Cash Flow History

20243.2 M
20232.7 M
20221.1 M
202113.3 M
202032 K
2019261 K

About Nexgel Financial Statements

Nexgel investors utilize fundamental indicators, such as End Period Cash Flow, to predict how Nexgel Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
End Period Cash Flow2.7 M3.2 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Nexgel Inc is a strong investment it is important to analyze Nexgel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nexgel's future performance. For an informed investment choice regarding Nexgel Stock, refer to the following important reports:
Check out the analysis of Nexgel Correlation against competitors.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexgel. If investors know Nexgel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexgel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.59)
Revenue Per Share
0.846
Quarterly Revenue Growth
0.234
Return On Assets
(0.23)
Return On Equity
(0.64)
The market value of Nexgel Inc is measured differently than its book value, which is the value of Nexgel that is recorded on the company's balance sheet. Investors also form their own opinion of Nexgel's value that differs from its market value or its book value, called intrinsic value, which is Nexgel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexgel's market value can be influenced by many factors that don't directly affect Nexgel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexgel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexgel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexgel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.